INTRODUCTION
Transmissible spongiform encephalopathies (TSEs) are a group of infectious diseases that include scrapie of sheep and goats, bovine spongiform encephalopathy (BSE), chronic wasting disease and various forms of CreutzfeldtJakob disease in humans. A series of TSE strains have been derived from these and other sources, which have been characterized by their incubation periods in inbred strains of mice carrying different genotypes of the PrP gene (originally identified as the Sinc gene) and by the amount and distribution of pathological lesions. The structure of the causal agents, specifically the molecular mechanisms by which the diverse phenotypic properties of TSE agents are encoded, have yet to be determined (Somerville, 2002) . Because of the range of interactions between different TSE strains and hosts of differing PrP genotype, the virino hypothesis proposes a model of the causal agent in which a host-independent informational molecule interacts with, and is protected by, a host protein, probably PrP (Farquhar et al., 1998) . This model is supported by the finding of differences in the intrinsic thermostability properties of different TSE strains, which suggest that the structure must contain at least two structurally dissimilar components . Other hypotheses suggest that PrP becomes infectious through a change in protein conformation (Prusiner, 1998) or that a conventional virus structure is consistent with the data (Chesebro, 1998) .
Whatever its role in the structure of the agent, it is clear that an abnormal form of PrP, normally denoted PrP Sc , is produced and deposited in infected tissues. PrP Sc differs from the normal form of the protein PrP C in several respects. PrP Sc tends to sediment after detergent treatment whereas PrP C is soluble, PrP Sc shows greater resistance to protease digestion than PrP C although the N terminus is cleaved (Meyer et al., 1986) . PrP Sc is often less glycosylated at its two N-glycosylation sites than PrP C (Hill et al., 1997; Kascsak et al., 1985; Somerville et al., 1997; Somerville & Ritchie, 1989) . The greatest degree of diversity in the degree of glycosylation is associated with differences in the strain of TSE agent, although other factors including tissue source (Hill et al., 1999) and the region of brain can also have a significant effect (Somerville, 1999) .
The apparent molecular mass of the aglycosyl form of the protein also varies. The variation is due to differential cleavage of PrP Sc at a series of sites between codons 80 and 100 (as numbered in the human PrP sequence), two of which, G82 and S97, tend to predominate, at least in humans (Bessen & Marsh, 1994; Hope et al., 1988; Parchi et al., 2000; reviewed by Schreuder & Somerville 2003) . Several cleavage sites have been identified in the same sample (Parchi et al., 2000) . The observed banding pattern of the aglycosyl PrP Sc polypeptide fragment on SDS-PAGE usually either appears as two bands or a single diffuse band, presumably corresponding to the two major protein IP: 54.70.40.11
On: Thu, 27 Dec 2018 10:53:54 fragments and/or an average of the migration of all the aglycosyl PrP Sc in the sample (Notari et al., 2004; Parchi et al., 2000) .
Because the diversity in glycosylation and cleavage of PrP Sc are associated with different TSE strains, it has been suggested that the degree of glycosylation of PrP Sc may be used as a differential diagnostic tool for TSEs (Hill et al., 1997) , for example between BSE and natural scrapie in sheep (Baron et al., 2000; Stack et al., 2002) . Time consuming traditional strain-typing techniques where incubation period and distribution of pathology are compared after passage in a panel of three or more strains of mice (Bruce et al., 1994) would be avoided. However, before the properties of PrP Sc can be exploited it is necessary to assess to what degree these properties are specified by the causal agent and by the host, including the effects of location in the brain.
In this study, we have investigated the effect of PrP genotype on the glycosylation of PrP Sc and show that some TSE strains differ in the degree to which they are glycosylated after passage in a new PrP genotype, while others show little change. In some, but not all, cases PrP genotype has an effect. In a previous publication we showed that brain region can have an effect on the degree of PrP Sc glycosylation (Somerville, 1999) . We have also examined the effect of brain region in more TSE models. Again in some, but not all, cases brain region has an effect.
METHODS
The methods used were similar to those used previously (Somerville, 1999) . Four TSE strains were previously isolated by serial passage (22C passaged six times, 79A passaged 12 times, 139A passaged eight times and 301C passaged six times) in C57BL, (Prnp aa ) mice and two strains were isolated by serial passage (22A passaged nine times and 301V passaged six times) in VM (Prnp bb ) mice. VM mice which carry the Prnp bb (Sinc p7p7 ) or the congenic equivalent SV mice carrying the Prnp aa (Sinc s7s7 ) allele of the PrP gene (Bruce et al., 1991) were injected intracerebrally with 20 ml of a 1 % brain homogenate from mice clinically infected with either 22A, 22C, 79A, 139A, 301C or 301V TSE strains. Once a defined clinical end point had been reached (Dickinson et al., 1968) , the mice were culled and brains removed and frozen at 270 uC. In each experiment three whole brains or three brains dissected into cortex, cerebellum and medulla were homogenized individually in lysis solution, digested with proteinase K and subjected to differential centrifugation as described previously (Collinge et al., 1996) . After centrifugation, SDS sample buffer was added to an aliquot of the supernatant, samples heated at 100 uC for 20 min and run on SDS-PAGE using the NuPage system and 12 % gels (Invitrogen). Gels were immunoblotted using the 6H4 anti-PrP monoclonal antibody (Prionics) and visualized with SuperSignal West Dura Extended Duration Substrate (Pierce) in a Kodak 440 Image station. The amount of each PrP Sc band, i.e. the upper diglycosyl band (H), the middle monoglycosyl band (L) and the lower aglycosyl band (U), was measured by determining the area under the curve generated by the PrP Sc signal, using Kodak Digital Science 1D software. For statistical comparisons, a Student's t-test of %H was performed on each pair of samples to be compared.
RESULTS AND DISCUSSION
The six passaged strains used in these experiments were isolated by serial passage in either C57BL (Prnp aa ) mice (79A, 139A, 22C and 301C) or VM (Prnp bb ) mice (22A and 301V). To prepare brains for analysis in the present experiments the six strains were injected into VM mice and SV (Prnp aa ) mice, which were bred to congenicity with VM mice over 20 generations (Bruce et al., 1991) . The incubation periods of the groups of mice from which brains were taken for analysis are shown in Fig. 1 .
Effect of TSE strain and PrP genotype
Examples of immunoblots for each model are shown in Fig. 2(a) and the measurement of the degree of glycosylation for each model is shown in Fig. 2(b) where the relative amounts of monoglycosyl PrP (%L) are plotted against the amounts of diglycosylated PrP (%H). The degree of glycosylation of 79A and 139A is low and similar after passage in both PrP genotypes. The 79A and 139A strains were originally derived from the 'drowsy goat' source by passage through C57BL mice. The 139A strain has been derived from the original mouse passage of this source (Chandler, 1961) , which was circulated to several laboratories as 'Chandler' or 'RML' strain. Indeed the only major phenotypic difference between the two strains is in their incubation periods, which in VM mice is about 100 days shorter for 139A than for 79A (Bruce et al., 1991) . The 79A and 139A strains are amongst the least glycosylated strains we have examined. It is worth noting that PrP Sc from another strain derived from the same 'drowsy goat' source, 263K strain in hamsters (Kimberlin & Walker, 1977) , is very highly glycosylated (Somerville et al., 1997) .
The 22C and 22A strains were derived by passage of the SSBP/1 experimental sheep scrapie source through C57BL and VM mice, respectively (Dickinson, 1976) . The PrP Sc from strain 22C-infected brains was slightly more heavily glycosylated, i.e. had more of the diglycosyl band, than PrP Sc from 79A-and 139A-infected brains. Little difference Fig. 1 . Incubation periods of TSE models (six TSE strains in two PrP genotypes: SV or VM) used in this paper. Incubation periods±standard errors of the mean (SEM) of groups of mice from which brains were used in these experiments were taken. Some of the SEM are small and may be hidden by the symbols.
was found in the glycosylation of 22C after passage through SV and VM mice. PrP Sc from 22A was more heavily glycosylated than 22C after continuing passage through VM mice but after a single passage through SV mice it was significantly less glycosylated than 22A from VM mice (Student's t-test of %H, P<0?05) and similar to PrP Sc from 22C. After serial passage in C57BL mice, 22A changes other phenotypic properties including incubation period and distribution of pathological lesions, although they remain dissimilar from those of 22C (Bruce & Dickinson, 1979) .
The 301C and 301V strains were derived by serial passage in C57BL and VM mice, respectively (Bruce et al., 1994) . In this case 301V shows little change in the degree of glycosylation after a single passage in SV mice. However, the degree of glycosylation of PrP Sc from 301C after a single passage in VM mice is reduced compared with PrP Sc from SV mice (Student's t-test of %H, P<0?005). Unfortunately, there yet has been no systematic study of the stability of other phenotypic properties of these two strains after passage in mouse PrP genotypes other than those in which they were first passaged. Perhaps other properties of 301C might diverge on serial passage in VM mice. Phenotypic changes of 87A changing to ME7 have been explained by mutation of the TSE agent's genome (Bruce & Dickinson, 1987) . Mutational change could well be responsible for the change in the properties of 22A and possibly the change in glycoform ratio of 301C.
Overall the results show that the degree to which PrP Sc is glycosylated can vary with strain of agent within the same PrP genotype after passage in either SV or VM mice (Fig. 2) . The strains 79A and 139A, derived from the 'drowsy goat' source (Dickinson, 1976) , were least glycosylated, while 301C and 301V which are derived from BSE were most heavily glycosylated. There was no detectable effect of PrP genotype on the degree of glycosylation of the Prnp aa passaged 22C, 79A, 139A or the Prnp bb passaged strain 301V. However with 22A, originally passaged in Prnp bb mice, there was a small but significant difference and with 301C originally passaged in Prnp aa mice there was a larger difference.
Effect of brain region
Previously we have found a small effect of PrP genotype on ME7 for which both the overall degree of glycosylation differed and the pattern of glycosylation in the monoglycosyl band varied according to PrP genotype (Somerville, 1999) . In the present experiments we examined the effect of brain region on the degree of glycosylation of PrP Sc from three TSE models by using TSE strains after continuing passage in the same PrP genotype in which they were originally isolated. The effect of passage in the alternate PrP genotype was not examined. Infected brains were dissected to obtain cortex, cerebellum and medulla. Differences were observed in the degree of glycosylation of PrP Sc from 301C and 301V with respect to brain region ( Fig. 3a and c) in accord with previous observations on ME7 (Somerville, 1999) . In particular, PrP Sc from 301C cerebellum was significantly more highly glycosylated than PrP Sc from 301C cortex (Student's t-test of %H, P<0?05) and PrP Sc from 301V cerebellum was significantly more highly glycosylated than PrP Sc from 301V medulla (%H, P<0?05) or cortex (%H, P<0?05). However, 22A showed no discernible difference between the three brain regions.
The simplest explanation for these observations is that PrP Sc is glycosylated to different degrees by different cell types. One could therefore speculate that 22A has affected similar cell types (or neuronal subtypes) but that 301C and 301V affect a wider range of cell types, which are possibly differentially distributed in the brain regions examined. It has been reported recently in sheep scrapie and experimental sheep BSE that PrP Sc is processed differently depending on TSE strain, host PrP genotype and location by different cell types within the same brain Jeffrey et al., 2003) .
Migration of the aglycosyl band
In all cases, except for 301C, the migration of the aglycosyl band was similar (Fig. 2a) . With 301C the aglycosyl band migrated faster in the sample from SV mice than from VM mice; the latter showed similar migration to 301V and indeed other strains examined (Fig. 2a and data not shown) .
The aglycosyl band in the brain region samples appeared to resolve more clearly into two bands (Fig. 3b) than from whole brain samples (Fig. 2a) , possibly reflecting the major cleavage sites in the sequence and also reflecting reduced heterogeneity. Whereas the 22A samples contained similar amounts of both aglycosyl bands, the 301V samples tended to have more of the faster migrating band, except in the sample from medulla where the amounts seem similar. In contrast, the samples from 301C predominantly contained the faster migrating band with evidence of even lower M r forms.
Strain typing using glycosylation of PrP Sc
Overall the results show that the strain of TSE agent has the greatest effect on the degree of glycosylation of PrP Sc . More minor effects are sometimes but not always associated with the location of PrP Sc in the brain. There were also minor differences in the degree to which PrP Sc was glycosylated after passage in mice of differing PrP genotypes in two cases, 22A and 301C. With the exception of 301C in SV mice, there was little variation in the aglycosyl band migration with respect to TSE strain, PrP genotype or brain region. However, 301C in SV mice had a predominance of the faster migrating aglycosyl band. These results demonstrate further that within a well-controlled and characterized experimental system, discriminatory phenotypic information about PrP Sc properties can be obtained. They also further confirm that tissue type and location, at which brain are sampled, can in principle significantly affect the measurements. These data also show that passage through hosts varying in PrP genotype can have significant effects on PrP Sc properties. If such changes were to occur in field cases of TSE disease they might compromise attempts to use PrP Sc properties for differential diagnosis/strain typing of TSEs. For example, it has been proposed that the differences in PrP Sc properties between cattle BSE and scrapie sheep PrP Sc might be used in the differential diagnosis of BSE in sheep (Baron et al., 2000; Stack et al., 2002) . However, such use might be compromised by changes in the PrP Sc properties of BSE on transmission to one or more PrP genotypes of sheep (Hunter et al., 2000) .
Origins of differential glycosylation
The diversity in structure of PrP Sc between and within TSE models and its difference from PrP C demands an assessment of possible mechanism(s) by which structural diversity arises. As discussed previously (Somerville, 1999) , PrP C is consistently highly glycosylated, but the degree of glycosylation of PrP Sc varies between strains and PrP Sc from some TSE models (e.g. 79A and 139A) is poorly glycosylated. Three possible models were proposed: (i) that PrP destined for the PrP Sc fraction follows a separate or modified biosynthetic path from that normally followed by PrP C (biosynthetic model); (ii) that the PrP to comprise PrP Sc was selected from the mature PrP C pool (selection model); or (iii) that the glycans were removed from PrP Sc during its conversion from mature PrP C (degradation model). Some preference is shown for PrP with similar degrees of glycosylation to the template in in vitro conversion assays although the host cell can also be influential (Vorberg & Priola, 2002) . Hence although the in vitro system demonstrated the feasibility of a selection hypothesis, it also showed that other factors affect the degree of glycosylation, suggesting that other mechanisms for determining the degree of glycosylation of PrP Sc might operate in vivo. Overall the data still favour the biosynthetic model (Somerville, 1999) .
The difference in apparent size of PrP Sc fragments after digestion with proteinase K is assumed to be due to differences in the conformation of the protein, which allows the protease differential access to cleavage sites (Caughey et al., 1998) . Cleavage properties are retained when PrP is converted to protease resistant forms in vitro (Bessen et al., 1995) , suggesting that a similar conversion mechanism might be followed in vivo. However, an alternative mechanism is more compatible with differences in glycosylation: that conformation of PrP Sc precursors is determined during post-translational maturation of the protein. Such diversity is compatible with the different relative amounts of the aglycosyl fragments observed in different brain regions. Indeed aberrant folding in the endoplasmic reticulum could well affect subsequent glycosylation. There are sequences in the 39 untranslated region of the PrP gene that modulate protein synthesis (Goldmann et al., 1999) , suggesting a mechanism of control via 39 (or possibly 59) elements in mRNA sequence. It has recently been proposed that PrP C controls the translation of HIV proteins Env and Vpr (Leblanc et al., 2004) . It is equally feasible that PrP C also regulates the translation of other proteins including itself.
